Since 2022, the continuous spread of highly pathogenic type A subtype H5N1 avian influenza virus has caused outbreaks in poultry worldwide. This has led to infections in various wildlife and domestic mammalian species, including recent outbreaks among cows in the United States (US), as well as s...
Certified reference material (CRM) EURM-014k has been produced in compliance with ISO 17034:2016 [1] and ISO 33405:2024 [2]. It is certified for the RNA identity and copy number. EURM-014k consists of a vacuum-dried synthetic single-stranded RNA (ssRNA) fragment deposited in a laser sealed singl...
The prevalence of autoimmune disorders is increasing worldwide. Whilst some treatments to manage symptoms do exist, there is a lack of effective options to stop and/or reverse the progression of the majority of these diseases. This is due in part to the fact that the causes and mechanisms of the...
The immune system defends our body from external threats, such as viruses, bacteria or allergens, and is able to distinguish these from our own cells. Sometimes however, it can falsely recognise constituent elements such as joint tissues or skin as being foreign and thus attacks them as a result...
This report presents an overview of available and emerging non-animal models in the field of cardiovascular disease (CVD) research. Over 14,000 abstracts published between 2013 and 2019 were scanned for relevant non-animal methods for CVD. From these, 449 publications were identified as candidat...
This report presents an overview of available and emerging non-animal models in the field of cardiovascular disease (CVD) research. Over 14,000 abstracts published between 2013 and 2019 were scanned for relevant non-animal methods for CVD. From these, 449 publications were identified as candidat...
Advanced therapy medicinal products (ATMPs) are a fast-growing class of innovative biological products. They include somatic cell therapy, gene therapy, tissue-engineering and their combinations, and they hold the key for new treatments for rare diseases and the establishment of personalised med...
Advanced therapy medicinal products (ATMPs) are a fast-growing class of innovative biological products. They include somatic cell therapy, gene therapy, tissue-engineering and their combinations, and they hold the key for new treatments for rare diseases and the establishment of personalised med...
The European Cancer Information System (ECIS) indicates that in the EU over 355,000 women were diagnosed with breast cancer in 2020 (13.3% of all cancer diagnoses). Despite advances in early detection and better understanding of the molecular bases of breast cancer biology, approximately 30% of ...
The European Cancer Information System (ECIS) indicates that in the EU over 355,000 women were diagnosed with breast cancer in 2020 (13.3% of all cancer diagnoses). Despite advances in early detection and better understanding of the molecular bases of breast cancer biology, approximately 30% of ...
